J. Michael Pearson has returned as the chief executive of Valeant Pharmaceuticals International after two months of medical leave, setting him up for the challenge of restoring investor confidence in the embattled company.
Valeant announced Sunday evening that Mr. Pearson had returned, effective immediately. Howard B. Schiller, who had been the interim chief executive in Mr. Pearson’s absence, will step down as a company executive but remain a member of the board.
16:16 Luxottica, Essilor $24 billion merger creates eyewear giant18
00:07 John Roberts will swear in another president. Maybe one day he’ll see a friendly face13
14:53 Netflix fueled by original programming, even as its costs hold earnings back, analysts say16
07:24 Burberry's CEO designate to join firm this month23